HCL Technologies Limited has completed its acquisition of a 10.46% stake in Indian artificial intelligence company Axonwise Private Limited (Sarvam AI) for ₹1,427.25 crores. The transaction was executed via the subscription and allotment of 41,421 Series B2 Compulsory Convertible Preference Shares on June 25, 2026.
NOIDA, India — Indian multinational information technology services provider HCL Technologies Limited (HCLTech) announced on June 25, 2026, that it has finalized its strategic equity acquisition in Axonwise Private Limited, widely known as Sarvam AI. The tech major deployed a total capital outlay of ₹1,427.25 crores to acquire a 10.46% stake in Sarvam AI, an artificial intelligence company incorporated in India. This development marks an important move by HCLTech to expand its generative AI capabilities and deepen its software portfolio amid an accelerating global corporate race to deploy indigenous enterprise AI solutions.
Technical Details of the Strategic AI Investment
According to the official compliance updates submitted by HCLTech to domestic bourses, the cross-industry transaction was completed on June 25, 2026, at approximately 6:00 P.M. IST. The finalization follows an initial corporate intimation letter dispatched by the company to regulatory bodies on June 15, 2026, outlining the broad parameters of the planned technology transaction.
The financial structure of the transaction shows that HCLTech completed the financial investment by subscribing to 41,421 Series B2 Compulsory Convertible Preference Shares ("Series B2 CCPS") issued by Axonwise Private Limited. The regulatory filing confirmed that these specialized Series B2 CCPS instruments were formally allotted to the enterprise on June 25, 2026, bringing a successful close to the transaction sequence. While the current stake is held through preference shares, these instruments are structurally bound to be converted into standard equity shares at a designated later date.
Expanding Enterprise Artificial Intelligence Footprint
Sarvam AI has emerged as a key developer within India's domestic artificial intelligence ecosystem, focusing on the creation of foundational large language models (LLMs) and voice-to-text architecture optimized for regional languages. For a global IT services integrator like HCLTech, securing a 10.46% stake in Sarvam AI provides structured access to specialized machine learning methodologies.
IT sector analysts note that by backing an automated language platform natively built for diverse regional semantics, HCLTech can enhance its global delivery centers. The deal allows the enterprise to build tailored automation, custom customer service bots, and localized generative AI applications for its multinational banking, healthcare, and public sector clientele. The partnership bypasses complete reliance on western hyperscale models, providing a cost-effective and highly secure alternative for processing corporate data.
Market Positioning and Structural Disclosures
The financial disclosures underpinning the multi-billion rupee investment were processed in complete alignment with the transparency guidelines dictated by the Securities and Exchange Board of India (SEBI). The corporate compliance documents were signed and certified by Manish Anand, Company Secretary of HCL Technologies Limited, before being transmitted to public exchange desks.
The regulatory data was synchronized across two major domestic listing platforms:
BSE Limited: Transmitted under the designated BSE Scrip Code 532281 to the Listing Department at Phiroze Jeejeebhoy Towers in Mumbai.
National Stock Exchange of India Limited: Transmitted under the NSE Scrip Code HCLTECH to the Exchange Plaza facility in the Bandra-Kurla Complex.
The administrative oversight for this multi-geography technology investment was anchored from HCLTech's global executive hub situated within the Special Economic Zone at Sector 126 in Noida, Uttar Pradesh.
Official Sources Section
The material facts, investment values, and shareholding percentages detailed within this report are drawn directly from the official market update documentation released by HCL Technologies Limited on June 25, 2026. All data reflects corporate regulatory notifications filed under the enterprise’s permanent Corporate Identity Number L74140DL1991PLC046369.
Quote Section
"According to officials familiar with the exchange filing, the capital allocation represents the formal completion of the binding agreements initiated earlier in the month. Organizers stated that the allotment of the 41,421 Series B2 Compulsory Convertible Preference Shares solidifies HCLTech's long-term intention to play an active, collaborative role in steering domestic AI development models toward mature enterprise scales."
Why It Matters
For enterprise software consumers and multinational clients, HCLTech’s major investment ensures that the IT giant can natively embed sophisticated, multi-lingual AI engines directly into its managed service offerings. For capital market investors and stock market analysts, the deployment of ₹1,427.25 crores shows a disciplined use of corporate cash reserves. The move targets a high-growth vertical capable of driving long-term consulting revenues, buffering the organization against slowing software spending cycles in traditional legacy infrastructure management markets.
Key Facts at a Glance
Financial Consideration: HCLTech deployed exactly ₹1,427.25 crores to complete the acquisition.
Equity Ownership: The investment secures a 10.46% stake in Indian AI pioneer Axonwise Private Limited (Sarvam AI).
Instrument Structure: The acquisition was executed by subscribing to 41,421 Series B2 Compulsory Convertible Preference Shares.
Final Allotment: The preference securities were formally allotted and closed on June 25, 2026, at 6:00 P.M. IST.
Frequently Asked Questions (FAQ)
What company did HCLTech invest in under this contract?
HCLTech invested in Axonwise Private Limited, an Indian technology company that operates under the commercial brand name Sarvam AI.
What specific type of financial instrument was utilized for this acquisition?
The transaction was completed through the subscription and allotment of 41,421 Series B2 Compulsory Convertible Preference Shares (CCPS), which are slated to convert into traditional equity shares later.
When was the transaction officially finalized with the stock exchanges?
The investment transaction was successfully completed and recorded on June 25, 2026, following an initial disclosure on June 15, 2026.
Source: Regulatory compliance updates submitted to BSE Limited and the National Stock Exchange of India Limited by HCL Technologies Limited.
